Lisa Rajah
About Lisa Rajah
Lisa Rajah serves as the Assistant Manager of Medical Affairs at Lucence, where she has been instrumental in advancing liquid biopsy technology. With extensive experience in clinical trials and a strong educational background in medical science, she has contributed significantly to the field through her work and research.
Work at Lucence Health
Currently, Lisa Rajah serves as the Assistant Manager in Medical Affairs at Lucence Health, a position she has held since 2023 in Austin, Texas. Previously, she worked as a Clinical Study Coordinator, also known as Local Clinical Study Manager, from 2021 to 2023 in Singapore. During her time at Lucence, she played a significant role in the company achieving Medicare coverage for liquid biopsy in lung cancer, marking a milestone for Asian start-ups in the healthcare sector.
Education and Expertise
Lisa Rajah has a strong educational background in medical science and related fields. She holds an Honours degree in Medical Science, Cellular and Molecular Pathology from the University of Bradford. Additionally, she has studied Medical Science at the University of Sydney and earned a Graduate Diploma in Clinical Research from Edinburgh Napier University. She is currently pursuing a Master's degree in Medical Physiology and Pharmacology at the University of Florida, expected to be completed in 2024. Furthermore, she has obtained a Professional Certificate in Statistics and R for Life Science from Harvard University and is studying Cancer Biology at The Johns Hopkins University.
Background in Clinical Trials
Lisa Rajah has extensive experience in clinical trials, having worked as a Clinical Trial Associate at Cambridge University Hospitals NHS Foundation Trust from 2002 to 2006. In this role, she contributed to various clinical studies in Cambridgeshire, England. Later, she served as Manager of Academic Operations at Uni-Challenge Consultants from 2017 to 2021 in Singapore, and as Head of Intramural Services at Republic Polytechnic from 2012 to 2016. Additionally, she has experience as a Lecturer in Genetics and Molecular Biology at Republic Polytechnic from 2010 to 2012.
Contributions to Clinical Research
Lisa Rajah has made significant contributions to clinical research, particularly in the area of liquid biopsy. She successfully managed clinical operations for a phase IV trial on liquid biopsy for non-small cell lung cancer (NSCLC) patients across 12 sites in the United States and Asia. She has also led evidence generation efforts to establish the clinical utility of liquid biopsy-based ctDNA and ctRNA panels. Her work has been recognized at international conferences, where she contributed to the publication of clinical trial data at events such as ISLB2022, NACLC2022, WCLC2023, and NACLC2023.